Seema Nagpal
Publications
- A case series of NSCLC patients with different molecular characteristics and choroidal metastases: improvement in vision with treatment including pemetrexed and bevacizumab. J Thorac Oncol. 2013; (2): e17-8
- A patient with anaplastic lymphoma kinase-positive non-small cell lung cancer with development of leptomeningeal carcinomatosis while on targeted treatment with crizotinib. J Natl Compr Canc Netw. 2013; (4): 389-94
- Advances in the management of glioblastoma: the role of temozolomide and MGMT testing. Clin Pharmacol. 2013: 1-9
- Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI. J Cereb Blood Flow Metab. 2013; (5): 732-43
- The incidence and significance of multiple lesions in glioblastoma. J Neurooncol. 2013; (1): 91-7
- Neoplastic myelopathy. Semin Neurol. 2012; (2): 137-45
- The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma. Neurosurg Clin N Am. 2012; (2): 289-95, ix
- Treatment of leptomeningeal spread of NSCLC: a continuing challenge. Curr Treat Options Oncol. 2012; (4): 491-504
- Bevacizumab improves quality of life in patients with recurrent glioblastoma. Chemother Res Pract. 2011: 602812
- Treatment and prophylaxis of hematologic malignancy in the central nervous system. Curr Treat Options Neurol. 2011; (4): 400-12
- Cardiac rupture after intravenous t-PA administration in acute ischemic stroke. Neurocrit Care. 2010; (2): 261-2
- Treatment and prevention of secondary CNS lymphoma. Semin Neurol. 2010; (3): 263-72
- Decompressive laparotomy to treat intractable cerebral hypoxia. J Trauma. 2009; (5): E152-5
- Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus. 2006; (3): E2
- Management of patients with schwannomatosis: report of six cases and review of the literature. Surg Neurol. 2004; (4): 353-61; discussion 361
Help
Trial Administration